Real-time enrollment status for this large granular lymphocytic leukemia clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 9:16 PM UTC
| NCT Number | NCT05475925 |
| Recruiting Status | Recruiting |
| Condition | Large Granular Lymphocytic Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 200 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Dren Bio |
| Last Updated on CT.gov | June 17, 2026 (Jun 17, 2026) |
As of September 1, 2026: Clinical trial NCT05475925 is currently recruiting participants. This phase1 study for large granular lymphocytic leukemia is actively seeking new participants at 15 locations across the United States. The study is sponsored by Dren Bio. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05475925 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05475925 was last updated Jun 17, 2026 (June 17, 2026). HelloStudys verifies this status automatically.